TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

(NU/1824) The Provision of Clinical Research Support & Central Laboratory Services for the ADVANCE Study

Research services
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Intelligence
Published evidence · v1
Prepared 7 Sept 2026, 20:35 BST
A pre-calculated analytical view of official UK procurement facts, competition benchmarks and decision timelines.
Bid readiness
Review notice
Submission deadline not published
Check official notice for submission route
Scope structure
1lots
1 lot · 1 published item
1 published CPV family
Decision Velocity
~50 days
Typical sector award window after deadline
Sector median: 50 days
Contract lifecycle
Not published
No future linked contract end in retained records
No published extension signal
Pricing & Budget Savings
Not published
Budget reduction not calculated
1 award supplier linked
Bidding Competition
2 bids
0 SME bids · 2 electronic
Bid price variance: 0.01% between lowest & highest
Sector Market Benchmark (CPV 73)
Based on 2,925 published procedures
Median Winning Discount
5.96%
Award reduction below published budget
Typical Bids Received
2 bidders
Median competitive participation in sector
Typical Evaluation Window
50 days
Median time between deadline and award
Top Contenders in this Sector (CPV 73)
Active commercial suppliers winning public contracts in this field
SupplierAwards won in sectorTotal awarded valueAvg. winning discount
18 contracts£64,987,779,553-5.2% below budget
18 contracts£2,814,722,069-12.2% below budget
WSP UK LTDCRN: PXHY-9498-VZNJ
11 contracts£39,474,946,186At ceiling / not disclosed
10 contracts£5,268,810,500-0.4% below budget
9 contracts£182,894,679At ceiling / not disclosed
AECOM LIMITEDCRN: 01846493
8 contracts£54,218,447,813-1.5% below budget
8 contracts£14,130,455,852At ceiling / not disclosed
GC INSIGHT LIMITEDCRN: 03162288
8 contracts£10,067,870At ceiling / not disclosed
Fera Science LtdCRN: PDGX-4332-VPXR
8 contracts£4,296,678-0.7% below budget
KPMG LLPCRN: OC301540
7 contracts£189,240,268,000At ceiling / not disclosed
Evidence coverage
7/12 core inputs published
Standard procedure facts
Comparable published opportunities
Historic records ranked from matching published evidence. They are research comparables, not expected competitors or a price forecast.
Published procedurePublished valueMatching evidence
Gambling Research ServicesGambling Commission · 13 Jul 2026, 16:30 BST
£500,000
same CPV family
Inter-Agency Debris Co-ordination Committee (IADC) Research Studies - 2026/27Department for Science, Innovation & Technology · 16 Jul 2026, 11:02 BST
£283,333
same CPV family
Clinical Research Monitoring, Quality Assurance and Site Support Services FrameworkLiverpool School of Tropical Medicine · 15 Jul 2026, 08:34 BST
£0
same CPV family
Wharton Data Research Services (WRDS) PlatformUniversity of Strathclyde · 27 Jul 2026, 11:49 BST
Value not published
same CPV family
Inclusive Growth (IG) FrameworkLondon Legacy Development Corporation · 20 Jul 2026, 11:57 BST
£70,000,000
same CPV family
Method: tender-intelligence-v1. Values and dates are retained OCDS facts; missing source data remains unknown.
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Newcastle University: "(NU/1824) The Provision of Clinical Research Support & Central Laboratory Services for the ADVANCE Study". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNewcastle UniversityScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Newcastle University
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Newcastle University. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
2Bids / Report (median)
38.8% of reports have one bid · Mean: 2.4 bids
Supplier ConcentrationHigh Concentration
Antaros Medical ABTop vendor: 87.1% of attributable value
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 104 active published awards; 98 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers in this Category (CPV 73):
Supplier NameHistoric AwardsAttributable ValueAvg. Price Discount
Antaros Medical AB1 win£3,576,286
Nordic Biosciences A/S1 win£527,354
Antaros Medical AB1 winNot disclosed
Histoindex pte Ltd1 winNot disclosed
ICON Clinical Research Ltd1 winNot disclosed
Procedure terms
Contracting AuthorityNewcastle University
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published4 Oct 2023, 15:24 BST
Last source update4 Oct 2023, 15:24 BST
Recurring procurementNot published
ClassificationResearch services
Delivery area
OCIDocds-h6vhtk-0387f3
What is being bought
The Newcastle University Translational and Clinical Research Institute is one of three research institutes established in 2019 following a restructure within the Faculty of Medical Sciences. Its members map across the biomedical research landscape. A number of major research projects are led from within the Institute including the “NASH Disease Translational Accelerator” (NASH-DTA) project. This project funded brings together clinicians and scientists from prominent academic centres across Europe and industrial partners to conduct research into advanced liver disease/cirrhosis caused by non-alcoholic fatty liver disease (NAFLD). Their common goals are developing, validating and qualifying better biomarkers for NAFLD. Strongly associated with the epidemics of obesity and type 2 diabetes that are testing healthcare systems worldwide, NAFLD is an increasingly common cause of advanced liver disease that is characterized by substantial inter-patient variability in severity and rate of progression. Biomarkers under investigation in the project include genes that contribute to NAFLD progression. The purpose of this tender process is to engage a supplier to provide clinical research support, central laboratory services and to oversee biological sample transfers and provide centralised laboratory processing of biological samples collected during the course of the study.
What changed
From the official release history
  1. tender value changed
    4 Oct 2023, 15:24 BST
  2. Status changed to complete
    4 Oct 2023, 15:24 BST
  3. Official notice release published
    4 Oct 2023, 15:24 BST
  4. Submission deadline changed to published date
    4 Oct 2023, 15:24 BST
  5. Published value updated to £2,200,000
    24 Nov 2022, 10:36 GMT
  6. Status changed to active
    24 Nov 2022, 10:36 GMT
  7. Official notice release published
    24 Nov 2022, 10:36 GMT
  8. Submission deadline changed to 5 Jan 2023, 12:00 GMT
    24 Nov 2022, 10:36 GMT
  9. Buyer information updated
    24 Nov 2022, 10:36 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    The purpose of this tender process is to engage a supplier to provide clinical research support, central laboratory services and to oversee biological sample transfers and provide centralised laboratory processing of biological samples collected during the course of the study.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    4 Oct 2023, 15:24 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 30 Aug 2023, 00:00 BST · Not published
Commercial outcome and competition
Awards
ICON Clinical Research Ltd
Not published · Not published · active
Contracts
The Provision of Clinical Research Support and Central Laboratory Services for the ADVANCE Study
Not published · signed 30 Aug 2023, 00:00 BST · active
Bid statistics
highestValidBidValue: 2000200
lowestValidBidValue: 2000000
bids: 2 (lot 1)
electronicBids: 2 (lot 1)
foreignBidsFromEU: 2 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
highestValidBidValue: 2000200 (lot 1)
lowestValidBidValue: 2000000 (lot 1)
smeBids: 0 (lot 1)
Buyer and organisations in this procedure

Newcastle University

Contracting authority GB-FTS-168
View buyer profile
  • Newcastle University
    buyer

    Newcastle University, Procurement Services, Kingsgate, Newcastle, UKC22, NE1 7RU
    +44 1912086298
  • ICON Clinical Research Ltd
    supplier

    South County Business Park, Leopardstown, Dublin, IE061, 18
  • Newcastle University
    reviewBody

    Newcastle upon Tyne
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published